Jubilant Life Sciences plans Rs 550-cr capex in FY19

img{border:0;clear:both;display:block;float:none;height:auto !important;margin: 3px 10px 3px 0;max-width:100% !important}
object, embed{border:0;clear:both;display:block;float:none}
a img{text-decoration:none}
p{clear:both}
.content * {font-family:’AvenirNext-Regular’, Avenir, ‘Helvetica Neue’, Arial, Helvetica, sans-serif;font-size:18px;line-height:1.4;color:#333 !important;}
font {line-height: inherit !important; font-size: inherit !important}
a, a:visited, .content a {color:#09f !important;text-decoration:none !important}
h1 a {color: white !important}

h1 {font-size:36px !important}
h2 {font-size:27px !important}
h3 {font-size:21px !important}
h4 {font-size:18px !important}
h5 {font-size:18px !important}
h6 {font-size:18px !important}
h1, h2, h3 { line-height: 1.125 !important }
h4, h5, h6 { line-height: 1.25 !important }

@media screen and (max-width:700px) {
.content {
width: 100%!important;
}
}

Pharma company Jubilant Life Sciences is planning to invest Rs 300 crore in research and development (R&D) in FY19.

via Industry-The Economic Times https://ift.tt/2Mriivm

RSS Feed


RSS feed to email


IFTTT